ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Sertraline → Sertraline, cis-(-)-

HRID 867999
印刷

反応式

HRID 867999 の反応式
[CH3:1][NH:2][C@@H:3]1[C:8]2[CH:9]=[CH:10][CH:11]=[CH:12][C:7]=2[C@H:6]([C:13]2[CH:14]=[CH:15][C:16]([Cl:20])=[C:17]([Cl:19])[CH:18]=2)[CH2:5][CH2:4]1.ClC1C=C(C(C2C=CC=CC=2)CCC(O)=O)C=CC=1Cl.ClC1C=C(C2C3C(=CC=CC=3)C(=O)CC2)C=CC=1Cl>>[CH3:1][NH:2][C@H:3]1[C:8]2[C:7](=[CH:12][CH:11]=[CH:10][CH:9]=2)[C@@H:6]([C:13]2[CH:14]=[CH:15][C:16]([Cl:20])=[C:17]([Cl:19])[CH:18]=2)[CH2:5][CH2:4]1
参加物実験手順出典と根拠反応ノート

参加物

4

反応物 3

HCID 68617SertralineHCID 37462514-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenoneHCID 99047234-(3,4-Dichlorophenyl)-4-phenylbutanoic acid

生成物 1

HCID 54375Sertraline, cis-(-)-

実験手順

As previously indicated, the 4-(3,4-dichlorophenyl)-4-phenylbutanoic acid final product afforded by the process of this invention is a valuable intermediate that ultimately leads to the antidepressant agent known as sertraline or cis-(1S) (4S)-N-methyl-4-(3,4-dichlorophenyl)-1, 2,3,4-tetrahydro-1-naphthaleneamine as disclosed in the previously discussed prior art. More specifically, 4-(3,4-dichlorophenyl)-4-phenylbutanoic acid is first converted to 4-(3,4-dichlorophenyl)-3, 4-dihydro-1-(2H)-naphthalenone and then finally to racemic cis-N-methyl-4-(3,4-dichlorophenyl)-1, 2,3,4-tetrahydro-1-naphthaleneamine prior to ultimately yielding the desired cis-(1S) (4S)-N-methyl-4-(3,4-dichlorophenyl)-1, 2,3,4-tetrahydro-1-naphthaleneamine by the multi-step method of the prior art process as earlier described by W.M. Welch, Jr. et al. in U.S. Pat. No. 4,536,518 and the Journal of Medicinal Chemistry, Vol. 27, No. 11, p. 1508 (1984).

出典と根拠

ORDレコード
ord-99645623274745aa8584a0a30c4cef90
出典データセット
uspto-grants-1988_10
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US04777288

反応ノート

このページの内容参加物実験手順出典と根拠反応ノート